FDA APPROVES MODERNA, PFIZER BIONTECH COVID-19 VACCINES
The country’s Food and Drugs Authority (FDA) has given approval for the importation, distribution and use of two additional Covid-19 vaccines in the country.
The approval of the two new vaccines; Moderna (Spikevax) and Pfizer BioNtech (Comirnaty) bring the total number of approved Covid-19 vaccines for use in the country to five.
Currently, the Covid-19 vaccines which have been approved by the FDA are the Sputnik V, Covishield TM and Covid-19 Vaccine Jassen.
In a press release to announce the new development, the FDA assured the public of its commitment to use the Emergency Use Authorization (El-JA) pathway, which is the accepted procedure for all national regulatory authorities globally, in order to ensure timely access to quality and safe medical products including vaccines during this pandemic.
READ ALSO: 163 CONVICTS ON DEATH ROW – ATTORNEY GENERAL
“The Authority therefore wishes to assure the public that all the approved COVID-19 vaccines have been subjected to rigorous safety parameters and therefore the public are to receive these vaccines without any reservations.
The FDA remains committed to safeguarding the health and safety of the public as mandated by the Public Health Act, 2012 (Act 851),” FDA CEO, Delese Darko said in the release.
The country’s Covid-19 mass vaccination campaign has witnessed a slow pace due to the global shortage of vaccines.
Since the exercise started in March this year just 405,971 persons have received the full dose of two jabs whilst 865,422 have received a single dose.